These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 22030299

  • 1. An assessment of R&D productivity in the pharmaceutical industry.
    Dimitri N.
    Trends Pharmacol Sci; 2011 Dec; 32(12):683-5. PubMed ID: 22030299
    [Abstract] [Full Text] [Related]

  • 2. Torching the Haystack: modelling fast-fail strategies in drug development.
    Lendrem DW, Lendrem BC.
    Drug Discov Today; 2013 Apr; 18(7-8):331-6. PubMed ID: 23246516
    [Abstract] [Full Text] [Related]

  • 3. What should be done to improve the productivity of neurological research?
    Moses H, Martin JB.
    Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925
    [No Abstract] [Full Text] [Related]

  • 4. Can emerging drug classes improve R&D productivity?
    Meier C, Cairns-Smith S, Schulze U.
    Drug Discov Today; 2013 Jul; 18(13-14):607-9. PubMed ID: 23702084
    [No Abstract] [Full Text] [Related]

  • 5. Mergers and innovation in the pharmaceutical industry.
    Comanor WS, Scherer FM.
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [Abstract] [Full Text] [Related]

  • 6. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA.
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [Abstract] [Full Text] [Related]

  • 7. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ.
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Driving clinical study efficiency by using a productivity breakdown model: comparative evaluation of a global clinical study and a similar Japanese study.
    Takahashi K, Sengoku S, Kimura H.
    J Clin Pharm Ther; 2011 Feb; 36(1):87-98. PubMed ID: 21198723
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ, Wyatt CA, Kleyn DE, Ayad A.
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [Abstract] [Full Text] [Related]

  • 14. Quality by design in lead optimization: a new strategy to address productivity in drug discovery.
    Rossi T, Braggio S.
    Curr Opin Pharmacol; 2011 Oct; 11(5):515-20. PubMed ID: 21652263
    [Abstract] [Full Text] [Related]

  • 15. Precompetitive research: a new prescription for drug development?
    Woodcock J.
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combating the cons of consolidation.
    Nat Rev Drug Discov; 2009 Mar; 8(3):177. PubMed ID: 19263592
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.